Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease. Currently, she serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. She is also the Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine.
Feldman has made contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. Her primary focus has been on amyotrophic lateral sclerosis (ALS), Alzheimer's disease, cognitive decline, and the neurologic complications of diabetes and obesity, as well as how environmental toxins affect the nervous system. She also has conducted pioneering research on developing stem cell therapies to treat these diseases.
Feldman is annually listed in Best Doctors in America, is a member of the Association of American Physicians and the National Academy of Medicine, and is a Fellow of the American Association for the Advancement of Science. Feldman has authored over 530 articles and 74 book chapters (Google Scholar h-index = 117) with >55,000 citations. She has been continuously NIH-funded since 1989 and has received numerous awards and honors throughout her remarkable career.